Support Us — Your donation helps us keep running

Goal: 1000 CNY,Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2019-13355
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
In Total Defense Anti-virus 9.0.0.773, insecure access control for the directory %PROGRAMDATA%\TotalDefense\Consumer\ISS\9\ used by ccschedulersvc.exe allows local attackers to hijack dotnetproxy.exe, which leads to privilege escalation when the ccSchedulerSVC service runs the executable.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Total Defense Anti-virus 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Total Defense Anti-virus是美国Total Defense公司的一套杀毒软件。 Total Defense Anti-virus 9.0.0.773版本中存在安全漏洞,该漏洞源于程序为ccschedulersvc.exe文件所使用的%PROGRAMDATA%TotalDefenseConsumerISS9路径执行了不安全的访问控制。本地攻击者可利用该漏洞劫持dotnetproxy.exe文件,进而提升权限。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2019-13355
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2019-13355
Please Login to view more intelligence information
New Vulnerabilities
V. Comments for CVE-2019-13355

No comments yet


Leave a comment